Vemics Inc. (VMCI) schneller Verdoppler ?! - 500 Beiträge pro Seite
eröffnet am 11.01.10 20:58:01 von
neuester Beitrag 21.06.10 22:24:20 von
neuester Beitrag 21.06.10 22:24:20 von
Beiträge: 35
ID: 1.155.256
ID: 1.155.256
Aufrufe heute: 0
Gesamt: 721
Gesamt: 721
Aktive User: 0
ISIN: US9225871006 · WKN: A0LC0F
0,0003
USD
-70,00 %
-0,0007 USD
Letzter Kurs 02.02.18 Nasdaq OTC
Neuigkeiten
Feedback
News erwartet für nächste Woche, Promo vermutlich danach ... hab grad zu 0,045 gekauft und es gibt noch welche. Ziel 0,1 bis nächste Woche ... danach, Newsabhängig und mal sehen.
120k heute zu 0.05 nachgekauft.
Naja, OB sowas von kontrolliert ... hier passiert noch einiges 
GL too all ...
GL too all ...
Hmm, wo die hinsoll ? weiß no ned ...
Antwort auf Beitrag Nr.: 38.721.517 von Bernhardow am 12.01.10 20:53:13Bin auch noch schnell aufgesprungen...da tut sich was
Deine Picks in letzter Zeit sind schmacke Treffer
Healthcare industries soll boomen
etwas DD
http://staging.imedicor.com/healthcare-insight.html
Deine Picks in letzter Zeit sind schmacke Treffer
Healthcare industries soll boomen
etwas DD
http://staging.imedicor.com/healthcare-insight.html
Trading Spotlight
Antwort auf Beitrag Nr.: 38.721.868 von TB303 am 12.01.10 21:31:24
Bleib vorsichtig aber ich bin ziemlich sicher ... die rockt.
Bleib vorsichtig aber ich bin ziemlich sicher ... die rockt.
Antwort auf Beitrag Nr.: 38.721.868 von TB303 am 12.01.10 21:31:24
Dank Dir übrigens auch nochmal für BGOI
Dank Dir übrigens auch nochmal für BGOI
Antwort auf Beitrag Nr.: 38.722.138 von Bernhardow am 12.01.10 21:57:48"bleib vorsichtig..."
Ich ebenfalls, bin aber auch dabei. Schaumer mal.
Ich ebenfalls, bin aber auch dabei. Schaumer mal.
Antwort auf Beitrag Nr.: 38.721.816 von Bernhardow am 12.01.10 21:24:39soll? gaaaanz weit hoch....wird...das wird man schon sehen 
2009-12-01
http://finance.yahoo.com/news/iMedicor-Signs-Master-Teaming-…
Excelicare solution in use:
http://www.axsys.co.uk/excelicare_in_use.htm
http://finance.yahoo.com/news/iMedicor-Signs-Master-Teaming-…
Excelicare solution in use:
http://www.axsys.co.uk/excelicare_in_use.htm
2009-11-12
http://biz.yahoo.com/e/091112/vmci.ob8-k.html
12-Nov-2009
Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Items 1.01. Entry into a Material Definitive Agreement
On November 5, 2009, Vemics, Inc., a Nevada corporation ( "Vemics"), entered into an Joint Marketing Agreement (the "Agreement") with Direct Medical Solutions Corporation, (DMS), a Connecticut Corporation, whereby, iMedicor will utilize DMS' national sales force of approximately 175 personnel to call on physicians, hospitals, Health Information Exchanges (HIEs) and other organizations in the healthcare field to enroll them into iMedicor's Portal and Vemics will actively promote membership in DMS throughout its iMedicor network. In addition the DMS sales group will represent iMedicor in promoting and selling upgrade products including it's partners' Health Information Exchange (HIE) and Electronic Medical Records (EMR) services, which are available via the iMedicor portal.
Under the terms of the Agreement iMedicor will pay to DMS on a monthly basis 17% of all net revenue generated from new iMedicor members who have joined the portal through DMS direct sales efforts, and DMS will pay to Vemics 17% of all revenue generated from new DMS members who have joined DMS through the iMedicor portal. The initial term of the Agreement is 2 years with automatic remewal on an annual basis unless either party notifies the other of their intent to terminate up to 90 days prior to the expiration of the Agreement.
http://biz.yahoo.com/e/091112/vmci.ob8-k.html
12-Nov-2009
Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Items 1.01. Entry into a Material Definitive Agreement
On November 5, 2009, Vemics, Inc., a Nevada corporation ( "Vemics"), entered into an Joint Marketing Agreement (the "Agreement") with Direct Medical Solutions Corporation, (DMS), a Connecticut Corporation, whereby, iMedicor will utilize DMS' national sales force of approximately 175 personnel to call on physicians, hospitals, Health Information Exchanges (HIEs) and other organizations in the healthcare field to enroll them into iMedicor's Portal and Vemics will actively promote membership in DMS throughout its iMedicor network. In addition the DMS sales group will represent iMedicor in promoting and selling upgrade products including it's partners' Health Information Exchange (HIE) and Electronic Medical Records (EMR) services, which are available via the iMedicor portal.
Under the terms of the Agreement iMedicor will pay to DMS on a monthly basis 17% of all net revenue generated from new iMedicor members who have joined the portal through DMS direct sales efforts, and DMS will pay to Vemics 17% of all revenue generated from new DMS members who have joined DMS through the iMedicor portal. The initial term of the Agreement is 2 years with automatic remewal on an annual basis unless either party notifies the other of their intent to terminate up to 90 days prior to the expiration of the Agreement.
Weekly schaut echt nett aus
http://biz.yahoo.com/e/091013/vmci.ob10-k.html
...
In February of 2009 we re-launched iMedicor as version 2.0 with completely redesigned functionality and security. During the redesign phase we focused less on increasing membership as to working with a core group of physician members to address functionality within the site and make recommended changes for the launch of the 2.0 version.
...
...
� Offering a secure and non-invasive online communications and information delivery tool for the dissemination of product-specific information provided by pharmaceutical and other healthcare related companies to physicians. Our first two customers in this area are scheduled to launch programs in January of 2010.
...
...
In February of 2009 we re-launched iMedicor as version 2.0 with completely redesigned functionality and security. During the redesign phase we focused less on increasing membership as to working with a core group of physician members to address functionality within the site and make recommended changes for the launch of the 2.0 version.
...
...
� Offering a secure and non-invasive online communications and information delivery tool for the dissemination of product-specific information provided by pharmaceutical and other healthcare related companies to physicians. Our first two customers in this area are scheduled to launch programs in January of 2010.
...
iMedicor Partners With Direct Medical Solutions for Marketing and Membership Development Services
NANUET, N.Y., Jan 19, 2010 (BUSINESS WIRE) --
iMedicor (OTCBB: VMCI) today announced that it has entered in to a strategic alliance with Direct Medical Solutions (DMS). Under the agreement, iMedicor will utilize the DMS national sales representatives to market enrollment and revenue generating services to physicians, hospitals, regional and state Health Information Exchanges (HIEs), and other organizations in the healthcare field.
Under the agreement, DMS will initially focus on enrolling oncologists, oncology related fields, neurologists and neurology related fields as the company begins to launch several contractual initiatives. DMS will also direct its efforts in promoting the Health Information Exchange / Electronic Medical Records system recently introduced by iMedicor. The HIE / EMR service was designed to address the Healthcare Initiative regulations that will begin to take effect later this year.
"This joint effort with Direct Medical represents a very constructive blending of our two business models," said Fred Zolla, CEO of iMedicor. "Direct Medical Solutions already has a substantial sales force on the ground, and we look forward to combining our assets to the benefit of both organizations."
Direct Medical Solutions Corp, currently privately held, has created a comprehensive offering of products and services for the medical community that generate additional revenue streams for medical practices, provide cost savings, streamline workflow, allow medical professions to achieve better patient compliance, assist medical practices and professionals by enhancing patient satisfaction.
"It's rare when you can help deliver greater profits to the health care industry at a lower cost and at the same time greatly improve the level of patient care and satisfaction," said Marian Bartosiewicz, CEO of Direct Medical Solutions Corp. "We look forward to working with iMedicor in this mutually beneficial alliance.
About iMedicor:
iMedicor is the only HIPAA-compliant solution for interoperable medical information transfer that is offered at no cost to healthcare providers and patients. The iMedicor portal also enables doctors, administrators and other qualified healthcare workers to send and receive medical records, files and images in a secure, HIPAA compliant environment; allows disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; and allows pharmaceutical companies to deliver customized marketing programs to healthcare providers nationwide in a highly targeted, cost-effective and non-intrusive manner. More information on iMedicor is available at www.imedicor.com.
About Direct Medical Solutions:
Direct Medical Solutions' business model is based on offering products and services for the medical community that generate additional revenue streams including an In-Office Pharmacy Management System; provide cost savings and streamline workflow; help patients save time and medical professions achieve better patient compliance; and assist medical practices and professional in finding ways to enhance patient satisfaction. More information on Direct Medical Solutions is available at www.directmedx.com.
The statements contained herein, other than historical information, are or may be deemed to be forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance of Vemics' products and services; the nonexclusive and terminable-at-will nature of certain of the company's partnerships and agreements; rapid technological change affecting demand for our products and services; competition from companies providing similar products and services, availability of sufficient financial resources to enable us to expand our operations, as well as other risks detailed from time to time in our filings with the Securities and Exchange Commission.
SOURCE: iMedicor
iMedicor Media:
Aimee Whitelaw, 202-997-1114
Communications Advisor
awhitelaw@imedicor.com
or
iMedicor Investor:
Craig Stout, 845-356-5211
Chief Operating Officer
cstout@imedicor.com
or
Direct Medical Solutions Media:
Michael O'Leary, 888-831-2418 ext. 106
Michael@directmedx.com
Copyright Business Wire 2010
NANUET, N.Y., Jan 19, 2010 (BUSINESS WIRE) --
iMedicor (OTCBB: VMCI) today announced that it has entered in to a strategic alliance with Direct Medical Solutions (DMS). Under the agreement, iMedicor will utilize the DMS national sales representatives to market enrollment and revenue generating services to physicians, hospitals, regional and state Health Information Exchanges (HIEs), and other organizations in the healthcare field.
Under the agreement, DMS will initially focus on enrolling oncologists, oncology related fields, neurologists and neurology related fields as the company begins to launch several contractual initiatives. DMS will also direct its efforts in promoting the Health Information Exchange / Electronic Medical Records system recently introduced by iMedicor. The HIE / EMR service was designed to address the Healthcare Initiative regulations that will begin to take effect later this year.
"This joint effort with Direct Medical represents a very constructive blending of our two business models," said Fred Zolla, CEO of iMedicor. "Direct Medical Solutions already has a substantial sales force on the ground, and we look forward to combining our assets to the benefit of both organizations."
Direct Medical Solutions Corp, currently privately held, has created a comprehensive offering of products and services for the medical community that generate additional revenue streams for medical practices, provide cost savings, streamline workflow, allow medical professions to achieve better patient compliance, assist medical practices and professionals by enhancing patient satisfaction.
"It's rare when you can help deliver greater profits to the health care industry at a lower cost and at the same time greatly improve the level of patient care and satisfaction," said Marian Bartosiewicz, CEO of Direct Medical Solutions Corp. "We look forward to working with iMedicor in this mutually beneficial alliance.
About iMedicor:
iMedicor is the only HIPAA-compliant solution for interoperable medical information transfer that is offered at no cost to healthcare providers and patients. The iMedicor portal also enables doctors, administrators and other qualified healthcare workers to send and receive medical records, files and images in a secure, HIPAA compliant environment; allows disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; and allows pharmaceutical companies to deliver customized marketing programs to healthcare providers nationwide in a highly targeted, cost-effective and non-intrusive manner. More information on iMedicor is available at www.imedicor.com.
About Direct Medical Solutions:
Direct Medical Solutions' business model is based on offering products and services for the medical community that generate additional revenue streams including an In-Office Pharmacy Management System; provide cost savings and streamline workflow; help patients save time and medical professions achieve better patient compliance; and assist medical practices and professional in finding ways to enhance patient satisfaction. More information on Direct Medical Solutions is available at www.directmedx.com.
The statements contained herein, other than historical information, are or may be deemed to be forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance of Vemics' products and services; the nonexclusive and terminable-at-will nature of certain of the company's partnerships and agreements; rapid technological change affecting demand for our products and services; competition from companies providing similar products and services, availability of sufficient financial resources to enable us to expand our operations, as well as other risks detailed from time to time in our filings with the Securities and Exchange Commission.
SOURCE: iMedicor
iMedicor Media:
Aimee Whitelaw, 202-997-1114
Communications Advisor
awhitelaw@imedicor.com
or
iMedicor Investor:
Craig Stout, 845-356-5211
Chief Operating Officer
cstout@imedicor.com
or
Direct Medical Solutions Media:
Michael O'Leary, 888-831-2418 ext. 106
Michael@directmedx.com
Copyright Business Wire 2010
Da kommt schon noch deutlich mehr ... Denke ich mal
Antwort auf Beitrag Nr.: 38.769.265 von TB303 am 19.01.10 23:20:34Die holt wohl grad tief Luft...
Der fehlt auch noch:
Antwort auf Beitrag Nr.: 38.777.381 von TB303 am 20.01.10 21:11:48
Dann hoffen wir mal das sie jetzt auch mal was bringt. Weggesteckt hat sie ja wohl sehr gut ...
Dann hoffen wir mal das sie jetzt auch mal was bringt. Weggesteckt hat sie ja wohl sehr gut ...
Antwort auf Beitrag Nr.: 38.801.284 von Bernhardow am 24.01.10 21:40:19Und heute wieder...die läuft noch wied sau
Aktuell a bisserl a Rohrkrepierer aber so ruhig, dass ich die Zeit zum verbilligen genutzt habe. Schaun mer mal, wies hier weitergeht.
Schaun mer mal, wies hier weitergeht.
Antwort auf Beitrag Nr.: 39.064.359 von Bernhardow am 04.03.10 22:26:42der schnelle Verdoppler zuckt gard in die richtige Richtung
Der gestrige Tag war super, konnte auch noch etwas verbilligen! 
Stoch könnte etwas besser sein
Siehe Chart Aber es wird ja auch Frühling, deswegen diese Temperaturen
ADX steht bei 16 , also unter 40 und das ist sehr gut
CCI ist im positiven Bereich bei 55
CMF ist auch positiv, also fließt Geld in die Aktie
Also ich würde sagen auf zu neuen Höhen
Stoch könnte etwas besser sein
Siehe Chart Aber es wird ja auch Frühling, deswegen diese Temperaturen ADX steht bei 16 , also unter 40 und das ist sehr gut
CCI ist im positiven Bereich bei 55
CMF ist auch positiv, also fließt Geld in die Aktie
Also ich würde sagen auf zu neuen Höhen
Antwort auf Beitrag Nr.: 38.801.284 von Bernhardow am 24.01.10 21:40:19Wie immer ein scharfes OB heute 
Hier tut sich charttechnisch etwas
Na zuviel versprochen
So, und nun durch die 65!
Naja schneller Verdoppler?
Ist die Frage wie man schnell definiert...........
Aber nix für ungut es scheint langsam wieder Volumen reinzukommen..................schaun wir mal.
Ist die Frage wie man schnell definiert...........
Aber nix für ungut es scheint langsam wieder Volumen reinzukommen..................schaun wir mal.
Solangsam kommt wohl wieder leben rein.
Ready for the next game.................
Ready for the next game.................
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| 0,00 | |
| - | |
| -0,23 | |
| - | |
| - | |
| - | |
| 0,00 | |
| +900,00 | |
| -84,00 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 240 | ||
| 107 | ||
| 82 | ||
| 78 | ||
| 75 | ||
| 53 | ||
| 41 | ||
| 38 | ||
| 36 | ||
| 34 |
